» Articles » PMID: 21629522

Implementation of Screening for Toxoplasma Gondii Infection in Pregnancy

Overview
Journal J Clin Med Res
Specialty General Medicine
Date 2011 Jun 2
PMID 21629522
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Since 1998, Italian law requires serological screening for toxoplasmosis by the thirteenth week of pregnancy, and seronegative women should undergo further checks every 30 - 40 days until delivery (a total of 5 - 7 screenings). This is an improvement of the previous law which foresaw three free tests (one by the end of the third month, one in the fifth, and one in the ninth month of pregnancy). The aim of this study was to assess the implementation, in an urban area of Northern Italy, of the 1998 law about 10 years after its entry into force.

Methods: Of the 4,694 women who initiated and completed a pregnancy in the period 2006 - 2008, we recorded the trimester of pregnancy in which they underwent their first screening, the total and average number of screenings during pregnancy, and the trimester distribution of the screenings.

Results: A total of 84.1% of the women underwent their first screening during the first trimester. The negative cases underwent an average of 3.7 screenings during pregnancy, with 34.9% undergoing five or more. Sixty percent of the women underwent at least one screening per trimester.

Conclusions: Our data indicates active screening during the first trimester, but fewer screenings than required by law during pregnancy as a whole. Therefore further efforts are needed to improve screening implementation.

Keywords: Anti-Toxoplasma antibodies; Congenital infection; Pregnancy trimester; Toxoplasma screening; Seroconversion; Seronegative women; Seropositive women; Screening protocol.

Citing Articles

Antenatal Screening for Toxoplasmosis and Rubella in Saudi Arabia: Assessing the Need for Screening.

Al-Mughales J, Al-Rabia M J Multidiscip Healthc. 2023; 16:3897-3905.

PMID: 38084119 PMC: 10710800. DOI: 10.2147/JMDH.S438895.


The Importance of Use of the On-line Databases as a Source for Systematic Review of Toxoplasmosis Screening During Pregnancy.

Voyiatzaki C, Orovas C, Trapali M, Chaniotis D, Kriebardis A, Beloukas A Acta Inform Med. 2021; 29(3):216-223.

PMID: 34759463 PMC: 8563042. DOI: 10.5455/aim.2021.29.216-223.


Evaluation of Three Point-of-Care Tests for Detection of Immunoglobulin IgG and IgM in the United States: Proof of Concept and Challenges.

Gomez C, Budvytyte L, Press C, Zhou L, McLeod R, Maldonado Y Open Forum Infect Dis. 2018; 5(10):ofy215.

PMID: 30393749 PMC: 6204989. DOI: 10.1093/ofid/ofy215.


Congenital Toxoplasmosis: A Plea for a Neglected Disease.

Wallon M, Peyron F Pathogens. 2018; 7(1).

PMID: 29473896 PMC: 5874751. DOI: 10.3390/pathogens7010025.


Age-associated prevalence of Toxoplasma gondii in 8281 pregnant women in Poland between 2004 and 2012.

Nowakowska D, Wujcicka W, Sobala W, Spiewak E, Gaj Z, Wilczynski J Epidemiol Infect. 2013; 142(3):656-61.

PMID: 23721799 PMC: 9151098. DOI: 10.1017/S0950268813001179.


References
1.
Aspock H, Pollak A . Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl. 1992; 84:32-7. View

2.
DESMONTS G, Couvreur J . [Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy]. Ann Pediatr (Paris). 1984; 31(10):805-9. View

3.
Charrier L, Moiraghi Ruggenini A, Renga G, Ditommaso S, Lievre M, Zotti C . [Cost analysis of toxoplasma infection control in pregnancy]. Ann Ig. 2004; 15(5):505-14. View

4.
Eskild A, Dahl G, Melby K, Nesheim B . Testing for toxoplasmosis in pregnancy: a study of the routines in primary antenatal care. J Med Screen. 2004; 10(4):172-5. DOI: 10.1258/096914103771773258. View

5.
Valcavi P, Natali A, Soliani L, Montali S, Dettori G, Cheezi C . Prevalence of anti-Toxoplasma gondii antibodies in the population of the area of Parma (Italy). Eur J Epidemiol. 1995; 11(3):333-7. DOI: 10.1007/BF01719439. View